跳至主要内容
临床试验/CTRI/2023/11/060096
CTRI/2023/11/060096尚未招募2 期

Evaluation of efficacy of adjunctive oral perampanel in children with Lennox Gastaut syndrome: a double-blind, placebo-controlled randomized trial - NI

Indian Council of Medical Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Participants must have a diagnosis of LGS as evidenced by: more than one type of generalized seizure, including drop seizures (atonic, tonic, or myoclonic) for at least 6 months before Visit 1; an electroencephalogram (EEG) reporting diagnostic criteria for LGS at some point in their history (abnormal background activity accompanied by slow, spike, and wave pattern <2.5 hertz [Hz]).
  • 2.Aged 4-18 years Participants must have experienced an average of at least 2 drop seizures per week in the 4-week
  • 3.Baseline Period preceding randomization: Participants must have been receiving 1 to 4 concomitant antiepileptic drugs (AEDs) at a stable dose for at least 30 days before Visit 1

排除标准

  • 1. Prior treatment with perampanel within 30 days of visit 1

研究者

相似试验